The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments.
COVID-19
Sars-CoV-2
biologics
psoriasis
synthetic and biological disease-modifying antirheumatic drugs (DMARDs)
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
02 Dec 2020
02 Dec 2020
Historique:
received:
17
11
2020
revised:
30
11
2020
accepted:
01
12
2020
entrez:
5
12
2020
pubmed:
6
12
2020
medline:
6
12
2020
Statut:
epublish
Résumé
Chronic plaque psoriasis is an inflammatory skin disease affecting 2-3% of the general population. Approximately one-third of patients are candidates for systemic immunosuppressive treatments, such as synthetic or biological disease-modifying antirheumatic drugs, because of disease extensions, localization in sensitive or visible areas and/or resistance to topical treatments. These therapies have been associated with increased risk of infection, including upper respiratory tract viral infection. Psoriasis is frequently associated with cardio-metabolic comorbidities, such as obesity and diabetes, that are risk factors for poor prognosis in the case of coronavirus disease (COVID-19) pneumonia. A narrative review of the literature based on an electronic search of the PubMed
Identifiants
pubmed: 33276686
pii: vaccines8040728
doi: 10.3390/vaccines8040728
pmc: PMC7761600
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Invest Dermatol. 2017 Feb;137(2):313-321
pubmed: 27677836
Nat Rev Immunol. 2020 Jun;20(6):345-346
pubmed: 32358580
Dermatol Reports. 2020 Jun 25;12(1):8642
pubmed: 32655846
Dermatol Ther (Heidelb). 2020 Aug;10(4):881-885
pubmed: 32468230
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e776-e778
pubmed: 32780905
Dermatol Ther. 2020 Jul 12;:e14011
pubmed: 32654404
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e676-e679
pubmed: 32564417
Dermatol Ther. 2020 Sep;33(5):e13475
pubmed: 32356577
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e363-e364
pubmed: 32379925
J Virol. 2002 Feb;76(3):1071-6
pubmed: 11773383
Dermatol Ther. 2020 Jul;33(4):e13706
pubmed: 32475056
J Eur Acad Dermatol Venereol. 2017 Dec;31(12):1951-1963
pubmed: 28895202
Int J Dermatol. 2019 Jun;58(6):649-658
pubmed: 30246393
J Cutan Med Surg. 2020 Nov/Dec;24(6):625-632
pubmed: 32757760
J Allergy Clin Immunol. 2020 Oct 16;:
pubmed: 33075408
Ann Rheum Dis. 2020 Feb;79(2):285-291
pubmed: 31672774
J Am Acad Dermatol. 2020 Oct;83(4):1215-1218
pubmed: 32622141
Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1562-1569
pubmed: 32975344
J Dermatolog Treat. 2020 Aug 4;:1-5
pubmed: 32705945
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e357-e358
pubmed: 32358791
Lancet. 2020 May 2;395(10234):1407-1409
pubmed: 32278362
J Cutan Med Surg. 2020 Sep 16;:1203475420960437
pubmed: 32936028
Am J Clin Dermatol. 2020 Oct;21(5):749-751
pubmed: 32812188
Dermatol Ther. 2020 Jul 3;:e13961
pubmed: 32618402
Int J Dermatol. 2020 Aug;59(8):e266-e267
pubmed: 32516447
Br J Dermatol. 2019 May;180(5):1039-1049
pubmed: 30485400
J Am Acad Dermatol. 2016 Jul;75(1):83-98.e4
pubmed: 27180926
Br J Dermatol. 2020 Aug;183(2):373-374
pubmed: 32343839
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
Dermatol Ther. 2020 Aug 14;:e14186
pubmed: 32794375
J Am Acad Dermatol. 2020 Aug;83(2):677-679
pubmed: 32416207
J Allergy Clin Immunol. 2020 Sep 28;:
pubmed: 33002515
Dermatol Ther. 2020 Jul;33(4):e13580
pubmed: 32406078
PLoS One. 2014 Feb 14;9(2):e88716
pubmed: 24551142
J Am Acad Dermatol. 2020 Oct 26;:
pubmed: 33122022
J Am Acad Dermatol. 2021 Jan;84(1):161-163
pubmed: 32860913
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e254-e255
pubmed: 32294258
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e360-e361
pubmed: 32379913
N Engl J Med. 2020 Jul 2;383(1):85-88
pubmed: 32348641
J Am Acad Dermatol. 2020 Oct;83(4):1212-1214
pubmed: 32679279
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e376-e378
pubmed: 32385859
J Dermatolog Treat. 2020 Oct 30;:1-5
pubmed: 32772743
J Am Acad Dermatol. 2020 Jul;83(1):285-287
pubmed: 32330632
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e770-e772
pubmed: 32735716
Dermatol Ther. 2020 Jul;33(4):e13739
pubmed: 32478942
Lancet. 2019 Aug 17;394(10198):576-586
pubmed: 31280967
Patient Prefer Adherence. 2020 Aug 07;14:1403-1409
pubmed: 32884243